SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-037100
Filing Date
2023-11-06
Accepted
2023-11-06 17:22:44
Documents
92
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aqst-20230930.htm   iXBRL 10-Q 1228244
2 EX-31.1 aqst-09302023ex311.htm EX-31.1 10889
3 EX-31.2 aqst-09302023ex312.htm EX-31.2 11105
4 EX-32.1 aqst-09302023ex321.htm EX-32.1 6389
5 EX-32.2 aqst-09302023ex322.htm EX-32.2 6455
  Complete submission text file 0001628280-23-037100.txt   7564049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20230930.xsd EX-101.SCH 63465
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aqst-20230930_cal.xml EX-101.CAL 67467
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aqst-20230930_def.xml EX-101.DEF 327746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20230930_lab.xml EX-101.LAB 745376
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20230930_pre.xml EX-101.PRE 542282
86 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20230930_htm.xml XML 907129
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 231380838
SIC: 2834 Pharmaceutical Preparations